Scott D Sandell - Net Worth and Insider Trading

Scott D Sandell Net Worth

The estimated net worth of Scott D Sandell is at least $3.5 Billion dollars as of 2024-04-27. Scott D Sandell is the 10% Owner of Tesaro Inc and owns about 10,420,645 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Scott D Sandell is the Director, 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,605,419 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Scott D Sandell is also the Director of Robinhood Markets Inc and owns about 23,850,644 shares of Robinhood Markets Inc (HOOD) stock worth over $426 Million. Besides these, Scott D Sandell also holds Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Adaptimmune Therapeutics PLC (ADAP) , Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Korro Bio Inc (KRRO) , Boingo Wireless Inc (WIFI) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Cloudflare Inc (NET) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Bloom Energy Corp (BE) , Inozyme Pharma Inc (INZY) , Tableau Software Inc (DATA) , Epizyme Inc (EPZM) , GlycoMimetics Inc (GLYC) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Workday Inc (WDAY) , Eargo Inc (EAR) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) . Details can be seen in Scott D Sandell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott D Sandell has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).

Transaction Summary of Scott D Sandell

To

Scott D Sandell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott D Sandell owns 108 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Mersana Therapeutics Inc (MRSN) among others .

Click here to see the complete history of Scott D Sandell’s form 4 insider trades.

Insider Ownership Summary of Scott D Sandell

Ticker Comapny Transaction Date Type of Owner
EAR Eargo Inc 2020-10-20 10 percent owner
MTCR Metacrine Inc 2021-12-22 10 percent owner
MRSN Mersana Therapeutics Inc 2020-04-14 10 percent owner
NET Cloudflare Inc 2023-11-20 director & 10 percent owner
SPT Sprout Social Inc 2019-12-12 10 percent owner
BE Bloom Energy Corp 2018-07-27 director & 10 percent owner
INZY Inozyme Pharma Inc 2020-07-28 10 percent owner
GNCAQ Genocea Biosciences Inc 2022-05-25 10 percent owner
ANNX Annexon Inc 2020-07-23 10 percent owner
NKTX Nkarta Inc 2020-07-09 10 percent owner
ARDX Ardelyx Inc 2021-12-15 10 percent owner
AKUS Akouos Inc 2020-06-30 10 percent owner
AVEO AVEO Pharmaceuticals Inc 2020-06-19 10 percent owner
SURF Surface Oncology Inc 2018-04-23 10 percent owner
SENS Senseonics Holdings Inc 2016-03-17 10 percent owner
TRVI Trevi Therapeutics Inc 2022-04-11 10 percent owner
RARX Ra Pharmaceuticals Inc 2020-04-02 10 percent owner
IMRA Imara Inc 2020-03-11 10 percent owner
CSBR Champions Oncology Inc 2015-03-11 10 percent owner
CSPR Casper Sleep Inc 2020-02-06 10 percent owner
BDTX Black Diamond Therapeutics Inc 2020-01-29 10 percent owner
ADAP Adaptimmune Therapeutics PLC 2020-01-24 10 percent owner
RGLS Regulus Therapeutics Inc 2020-12-04 10 percent owner
PTI Proteostasis Therapeutics Inc 2019-11-26 10 percent owner
GRTX Galera Therapeutics Inc 2019-11-06 10 percent owner
OYST Oyster Point Pharma Inc 2019-10-30 10 percent owner
MIRM Mirum Pharmaceuticals Inc 2019-07-22 10 percent owner
NITE Nightstar Therapeutics PLC 2019-06-07 10 percent owner
TSRO Tesaro Inc 2019-01-22 10 percent owner
MLND Millendo Therapeutics Inc 2018-12-07 10 percent owner
PHASQ PhaseBio Pharmaceuticals Inc 2018-10-17 10 percent owner
MRKR Marker Therapeutics Inc 2021-03-16 10 percent owner
ESTC Elastic NV 2018-10-04 10 percent owner
LQDA Liquidia Corp 2018-07-30 10 percent owner
GLYC GlycoMimetics Inc 2023-01-26 10 percent owner
MULE MuleSoft Inc 2018-05-01 10 percent owner
TCON TRACON Pharmaceuticals Inc 2018-03-27 10 percent owner
CASC Cascadian Therapeutics Inc 2018-03-09 10 percent owner
ABIO ARCA biopharma Inc 2018-02-26 10 percent owner
TNTRQ Tintri Inc 2018-02-26 10 percent owner
APPN Appian Corp 2017-11-27 10 percent owner
SYBX Synlogic Inc 2015-09-30 10 percent owner
SBBP Strongbridge Biopharma PLC 2018-01-01 10 percent owner
XFOR X4 Pharmaceuticals Inc 2017-11-20 10 percent owner
CRCM Care.com Inc 2017-11-06 10 percent owner
RYTM Rhythm Pharmaceuticals Inc 2017-10-10 10 percent owner
ZSANQ Zosano Pharma Corp 2015-01-26 10 percent owner
AKAOQ Achaogen Inc 2016-12-19 10 percent owner
ROKA Sorrento Tech Inc 2016-09-21 10 percent owner
ILIU Interleukin Genetics Inc 2016-07-29 10 percent owner
OPWR Opower Inc 2016-06-14 10 percent owner
TRIV TriVascular Technologies Inc 2016-02-03 10 percent owner
EPZM Epizyme Inc 2016-01-12 10 percent owner
SUPN Supernus Pharmaceuticals Inc 2015-06-17 10 percent owner
AVTX Avalo Therapeutics Inc 2015-10-14 10 percent owner
VTAE Vitae Pharmaceuticals Inc 2015-07-01 10 percent owner
BOX Box Inc 2015-01-22 10 percent owner
WIFI Boingo Wireless Inc 2014-12-19 10 percent owner
TRVN Trevena Inc 2014-01-30 10 percent owner
DATA Tableau Software Inc 2014-12-05 director
CVT Cvent Inc 2014-11-25 10 percent owner
DERM Dermira Inc 2014-10-08 10 percent owner
SNSS Sunesis Pharmaceuticals Inc 2014-08-27 10 percent owner
LOXO Loxo Oncology Inc 2014-08-06 10 percent owner
HIVE Aerohive Networks Inc 2014-04-02 10 percent owner
WDAY Workday Inc 2014-02-28 director & 10 percent owner
ECOM ChannelAdvisor Corp 2013-05-22 10 percent owner
CBIO Catalyst Biosciences Inc 2013-12-05 10 percent owner
XOOM Xoom Corp 2013-10-29 10 percent owner
GRPN Groupon Inc 2013-08-15 10 percent owner
CLVSQ Clovis Oncology Inc 2011-11-21 10 percent owner
MM Millennial Media Inc 2012-10-29 10 percent owner
INWK InnerWorkings Inc 2012-03-28 10 percent owner
FOLD Amicus Therapeutics Inc 2007-05-30 10 percent owner
ECHO Echo Global Logistics Inc 2009-10-01 10 percent owner
GLUU Glu Mobile Inc 2011-08-08 10 percent owner
VG Vonage Holdings Corp 2006-05-23 10 percent owner
ARYX ARYx Therapeutics Inc 2011-03-10 10 percent owner
VLTC Voltari Corp 2010-06-23 10 percent owner
WWHC W World Corp 2009-05-08 10 percent owner
IQNT Inteliquent Inc 2009-02-20 10 percent owner
PRTK Paratek Pharmaceuticals Inc 2006-05-09 10 percent owner
ARDMQ Aradigm Corp 2003-12-31 10 percent owner
VIRX Viracta Therapeutics Inc 2009-04-03 10 percent owner
SVRA Savara Inc 2023-07-17 10 percent owner
CVRX CVRx Inc 2021-06-29 10 percent owner
YMTX Yumanity Therapeutics Inc 2016-02-10 10 percent owner
UTRS Minerva Surgical Inc 2021-10-21 10 percent owner
TPST Tempest Therapeutics Inc 2018-12-07 10 percent owner
RPHM Reneo Pharmaceuticals Inc 2021-04-08 10 percent owner
COUR Coursera Inc 2021-03-30 director & 10 percent owner
VRNA Verona Pharma PLC 2021-01-01 10 percent owner
NEUE NeueHealth Inc 2021-06-24 10 percent owner
DM Desktop Metal Inc 2020-12-09 10 percent owner
HOOD Robinhood Markets Inc 2022-05-12 director & 10 percent owner
ACLX Arcellx Inc 2022-12-23 10 percent owner
BGRY Berkshire Grey Inc 2021-07-21 10 percent owner
IONQ IonQ Inc 2021-09-30 10 percent owner
GLUE Monte Rosa Therapeutics Inc 2021-06-23 10 percent owner
BZFD BuzzFeed Inc 2021-12-03 10 percent owner
SNTI Senti Biosciences Inc 2022-06-08 10 percent owner
ZFOX ZeroFox Holdings Inc 2022-08-03 10 percent owner
KA Kineta Inc 2016-02-10 10 percent owner
ELVN Enliven Therapeutics Inc 2020-03-11 10 percent owner
GGNNQ Genocea Biosciences Inc 2018-01-19 10 percent owner
SGMT Sagimet Biosciences Inc 2023-07-13 10 percent owner
RAACU Revolution Acceleration Acquisition Corp 2021-07-21 10 percent owner
KRRO Korro Bio Inc 2024-04-22 10 percent owner

Scott D Sandell Latest Holdings Summary

Scott D Sandell currently owns a total of 44 stocks. Among these stocks, Scott D Sandell owns 10,420,645 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 22.49%. Scott D Sandell owns 13,605,419 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 12.49%. Scott D Sandell also owns 23,850,644 shares of Robinhood Markets Inc (HOOD) as of May 12, 2022, with a value of $426 Million and a weighting of 12.28%. The other 41 stocks Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Adaptimmune Therapeutics PLC (ADAP) , Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Korro Bio Inc (KRRO) , Boingo Wireless Inc (WIFI) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Cloudflare Inc (NET) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Bloom Energy Corp (BE) , Inozyme Pharma Inc (INZY) , Tableau Software Inc (DATA) , Epizyme Inc (EPZM) , GlycoMimetics Inc (GLYC) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Workday Inc (WDAY) , Eargo Inc (EAR) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) have a combined weighting of 52.73% among all his current holdings.

Latest Holdings of Scott D Sandell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSRO Tesaro Inc 2018-03-06 10,420,645 74.96 781,131,549
FNIO iShares Indl/Office Real Estate Capped 2012-04-30 13,605,419 31.89 433,876,812
HOOD Robinhood Markets Inc 2022-05-12 23,850,644 17.88 426,449,515
ACLX Arcellx Inc 2022-12-23 4,746,494 51.92 246,437,968
SUPN Supernus Pharmaceuticals Inc 2015-06-17 7,641,250 30.07 229,772,388
RYTM Rhythm Pharmaceuticals Inc 2017-10-10 4,909,956 38.28 187,953,116
RARX Ra Pharmaceuticals Inc 2016-10-31 3,490,073 47.99 167,488,603
ECHO Echo Global Logistics Inc 2009-10-01 2,420,219 48.24 116,751,365
ADAP Adaptimmune Therapeutics PLC 2020-01-24 102,478,668 1.08 110,164,568
SVRA Savara Inc 2023-07-17 24,471,264 4.41 107,918,274
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 24.46 102,395,504
ARDX Ardelyx Inc 2021-12-15 10,752,106 6.42 69,028,521
KRRO Korro Bio Inc 2024-04-22 1,090,793 62.93 68,643,603
WIFI Boingo Wireless Inc 2013-12-11 4,467,960 13.99 62,506,760
AVEO AVEO Pharmaceuticals Inc 2020-06-19 3,952,958 15.00 59,294,370
AKUS Akouos Inc 2020-06-30 4,294,207 13.29 57,070,011
GRPN Groupon Inc 2013-08-15 3,709,248 11.67 43,286,924
TRVI Trevi Therapeutics Inc 2022-04-11 11,370,376 2.78 31,609,645
LQDA Liquidia Corp 2018-07-30 2,484,870 12.53 31,135,421
MRSN Mersana Therapeutics Inc 2020-04-14 7,959,520 2.94 23,400,989
NET Cloudflare Inc 2023-11-20 217,859 88.01 19,173,771
INWK InnerWorkings Inc 2012-02-29 6,029,190 2.99 18,027,278
MM Millennial Media Inc 2012-10-29 8,196,614 1.75 14,344,075
BE Bloom Energy Corp 2018-07-27 1,333,333 10.60 14,133,330
INZY Inozyme Pharma Inc 2020-07-28 2,437,689 4.44 10,823,339
DATA Tableau Software Inc 2014-12-05 55,705 169.53 9,443,669
EPZM Epizyme Inc 2016-01-12 6,261,502 1.47 9,204,408
GLYC GlycoMimetics Inc 2023-01-26 4,967,530 1.64 8,146,749
MRKR Marker Therapeutics Inc 2021-03-16 1,071,429 4.29 4,596,430
SURF Surface Oncology Inc 2018-04-23 3,312,877 1.07 3,544,778
RGLS Regulus Therapeutics Inc 2020-12-04 645,106 2.42 1,561,157
WDAY Workday Inc 2014-02-28 5,088 251.04 1,277,292
EAR Eargo Inc 2020-10-20 326,001 2.57 837,823
CBIO Catalyst Biosciences Inc 2013-12-05 43,462 7.67 333,332
DERM Dermira Inc 2014-10-02 17,241 18.75 323,269
ILIU Interleukin Genetics Inc 2016-07-29 55,418,811 0.00 249,385
AKAOQ Achaogen Inc 2016-12-19 5,215,128 0.03 130,378
CLVSQ Clovis Oncology Inc 2011-11-21 3,419,671 0.02 51,295
TCON TRACON Pharmaceuticals Inc 2018-03-27 17,330 1.81 31,367
MTCR Metacrine Inc 2021-12-22 2,563,257 0.00 3,589
NOVCQ Novation Companies Inc 2006-05-15 1,225,179 0.00 123
ABIO ARCA biopharma Inc 2018-02-26 0 3.58 0
GNCAQ Genocea Biosciences Inc 2022-05-25 0 0.00 0
APPN Appian Corp 2017-11-27 0 37.56 0

Holding Weightings of Scott D Sandell


Scott D Sandell Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott D Sandell has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Scott D Sandell around $8 Million.

According to the SEC Form 4 filings, Scott D Sandell has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 20,249 shares on April 30, 2012, which brought Scott D Sandell around $535,586.

According to the SEC Form 4 filings, Scott D Sandell has made a total of 3 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Robinhood Markets Inc is the sale of 8,792 shares on May 12, 2022, which brought Scott D Sandell around $73,941.

More details on Scott D Sandell's insider transactions can be found in the Insider Trading History of Scott D Sandell table.

Insider Trading History of Scott D Sandell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott D Sandell Trading Performance

GuruFocus tracks the stock performance after each of Scott D Sandell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott D Sandell is 8.02%. GuruFocus also compares Scott D Sandell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott D Sandell within 3 months outperforms 32 times out of 57 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott D Sandell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott D Sandell

Average Return

-20.8%

Average return per transaction

Outperforming Transactions

24%

13 out of 55 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.31 8.02 5.48 -20.8 -31.06 -27.49
Relative Return to S&P 500(%) 5.48 5.13 -1.32 -34.93 -41.82 -39.91

Scott D Sandell Ownership Network

Ownership Network List of Scott D Sandell

No Data

Ownership Network Relation of Scott D Sandell


Scott D Sandell Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Scott D Sandell is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Scott D Sandell Mailing Address

Above is the net worth, insider trading, and ownership report for Scott D Sandell. Currently GuruFocus does not have mailing address information for Scott D Sandell.

Discussions on Scott D Sandell

No discussions yet.